​

Orchestra BioMed (OBIO) Revenue & Revenue Breakdown

OverviewFinancialsChart

Orchestra BioMed Revenue Highlights

Latest Revenue (Y)

$2.76M

Latest Revenue (Q)

$778.00K

Main Segment (Y)

Product

Orchestra BioMed Revenue by Period

Orchestra BioMed Revenue by Year

DateRevenueChange
2023-12-31$2.76M-21.88%
2022-12-31$3.53M-551.79%
2021-12-31$-782.00K-113.71%
2020-12-31$5.70M-

Orchestra BioMed generated $2.76M in revenue during NA 2023, up -21.88% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Orchestra BioMed Revenue by Quarter

DateRevenueChange
2024-06-30$778.00K25.48%
2024-03-31$620.00K136.64%
2023-12-31$262.00K-37.47%
2023-09-30$419.00K-54.21%
2023-06-30$915.00K-21.39%
2023-03-31$1.16M5.53%
2022-12-31$1.10M-5.16%
2022-09-30$1.16M190.02%
2022-06-30$401.00K-53.70%
2022-03-31$866.00K-135.30%
2021-12-31$-2.45M-284.02%
2021-09-30$1.33M-236.30%
2021-06-30$-978.00K-174.32%
2021-03-31$1.32M-

Orchestra BioMed generated $778.00K in revenue during Q2 2024, up 25.48% compared to the previous quarter, and up 66.84% compared to the same period a year ago.

Orchestra BioMed Revenue Breakdown

Orchestra BioMed Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23
Product$654.00K

Orchestra BioMed's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24
Product$184.00K$123.00K

Orchestra BioMed's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (100.00%).

OBIO Revenue FAQ

What is Orchestra BioMed’s yearly revenue?

Orchestra BioMed's yearly revenue for 2023 was $2.76M, representing a decrease of -21.88% compared to 2022. The company's yearly revenue for 2022 was $3.53M, representing a decrease of -551.79% compared to 2021. OBIO's yearly revenue for 2021 was $-782K, representing a decrease of -113.71% compared to 2020.

What is Orchestra BioMed’s quarterly revenue?

Orchestra BioMed's quarterly revenue for Q2 2024 was $778K, a 25.48% increase from the previous quarter (Q1 2024), and a -14.97% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $620K, a 136.64% increase from the previous quarter (Q4 2023), and a -46.74% decrease year-over-year (Q1 2023). OBIO's quarterly revenue for Q4 2023 was $262K, a -37.47% decrease from the previous quarter (Q3 2023), and a -76.25% decrease year-over-year (Q4 2022).

What is Orchestra BioMed’s revenue growth rate?

Orchestra BioMed's revenue growth rate for the last 3 years (2021-2023) was -452.94%

What are Orchestra BioMed’s revenue streams?

Orchestra BioMed's revenue streams in c 23 are Product

What is Orchestra BioMed’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Orchestra BioMed was Product. This segment made a revenue of $654K, representing 100.00% of the company's total revenue.